Skip to main content
. Author manuscript; available in PMC: 2019 Feb 4.
Published in final edited form as: Oncogene. 2003 Oct 20;22(47):7369–7375. doi: 10.1038/sj.onc.1206940

Table 3.

Anticancer agents associated with increased levels of GST and resistance

Substrates of GST
 Chlorambucil
 Melphalan
 Nitrogen mustard
 Phosphoramide mustard
 Acrolein
 Carmustine
 Hydroxyalkenals
 Ethacrynic acid
 Steroids
Not characterized as substrates
 Antimetabolites*
 Antimicrotubule drugs*
 Topoisomerase I & II inhibitors*
 Bleomycin
 Hepsulfam
 Mitomycin C*
 Adriamycin*
 Cisplatin*
 Carboplatin
*

Require JNK activation for cytotoxicity